Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EBITDA: 2009-2024

Historic EBITDA for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $608,000.

  • Rockwell Medical's EBITDA fell 181.82% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 million, marking a year-over-year decrease of 929.66%. This contributed to the annual value of $608,000 for FY2024, which is 109.12% up from last year.
  • Per Rockwell Medical's latest filing, its EBITDA stood at $608,000 for FY2024, which was up 109.12% from -$6.7 million recorded in FY2023.
  • Rockwell Medical's 5-year EBITDA high stood at $608,000 for FY2024, and its period low was -$30.3 million during FY2021.
  • Moreover, its 3-year median value for EBITDA was -$6.7 million (2023), whereas its average is -$7.6 million.
  • Per our database at Business Quant, Rockwell Medical's EBITDA dropped by 6.74% in 2021 and then skyrocketed by 109.12% in 2024.
  • Rockwell Medical's EBITDA (Yearly) stood at -$28.4 million in 2020, then decreased by 6.74% to -$30.3 million in 2021, then skyrocketed by 44.69% to -$16.8 million in 2022, then spiked by 60.25% to -$6.7 million in 2023, then surged by 109.12% to $608,000 in 2024.